Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | BRS3 | P32247 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17437659 | 0.89 | CA12 (0.36) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17437664 | 0.89 | CA12 (0.36) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17437662 | 0.89 | CA12 (0.36) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17449867 | 0.88 | CA12 (0.40) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17437673 | 0.81 | CYP3A4 (0.37) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17437671 | 0.81 | CYP3A4 (0.37) | CA12CA14CA2CA1CA7 | |
| SCHEMBL17437672 | 0.81 | CYP3A4 (0.37) | CA12CA14CA2CA1CA7 | |
| SCHEMBL10015600 | 0.76 | BTK (0.39) | BTK | |
| SCHEMBL17472894 | 0.75 | BTK (0.38) | BTK | |
| SCHEMBL17449869 | 0.74 | BTK (0.39) | BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2980067-B1 | PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-2980067-A1 | PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-02-03 | — | — | EP | disclosed |